Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KLK7 | P49862 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28496796 | 0.98 | MMP1 (0.38) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL13843609 | 0.91 | MMP1 (0.34) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL4263080 | 0.91 | MMP1 (0.34) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL2608669 | 0.82 | LMNA (0.40) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL7110445 | 0.82 | LMNA (0.40) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL2520414 | 0.81 | LMNA (0.36) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL18610918 | 0.81 | TSHR (0.34) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL9268142 | 0.81 | MMP1 (0.45) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL16359872 | 0.80 | MMP1 (0.31) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL12900262 | 0.80 | MMP1 (0.31) | MMP1MMP2MMP3MMP9MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083669-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2026-03-26 | — | — | US | claimed |
| EP-4658273-A2 | LONG-ACTING INJECTABLE (LAI) COMPOSITION OF CARIPRAZINE | Foresee Pharmaceuticals Co., Ltd. (TW) | 2025-12-10 | — | — | EP | claimed |
| CN-120059223-A | Composite polyester material and preparation method and application thereof | 南方医科大学 | 2025-05-30 | — | — | CN | claimed |
| EP-4541384-A1 | COMPOSITE, METHOD FOR MANUFACTURING SAME, AND FILLER COMPOSITION FOR MOLDING, USING SAME | Vaim Co. Ltd. (KR) | 2025-04-23 | — | — | EP | claimed |
| US-20250073343-A1 | PROTEIN-LOADED PLGA NANOSPHERES | WEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV (US) | 2025-03-06 | — | — | US | claimed |
| CN-119523940-A | Nanoparticle embedded with mitochondrial fission inhibitor and preparation method and application thereof | 吉林大学 | 2025-02-28 | — | — | CN | claimed |
| US-20250064949-A1 | PROTEIN-LOADED PLGA NANOSPHERES | WEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV (US) | 2025-02-27 | — | — | US | claimed |
| CN-119367591-A | Collagen hydrogel for logically releasing cerium oxide nanoparticles and iron oxide nanoparticles, preparation method and application | 胶原蛋白(武汉)生物科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119236176-A | Tissue engineering intervertebral disc and preparation method and application thereof | 青岛大学 | 2025-01-03 | — | — | CN | claimed |
| CN-119033952-A | Preparation method and application of Dual-heavy-duty drug Dual-targeting nano drug delivery System (Dual-Nanodrug-System) | 南方医科大学南方医院 | 2024-11-29 | — | — | CN | claimed |
| CN-112469397-B | Nanoparticles comprising bioresorbable polyester, hydrophilic polymer and acylated human lactoferrin derived peptide | 赢创运营有限公司 | 2022-12-02 | — | — | CN | claimed |
| EP-4072536-A1 | PROTEIN-LOADED PLGA NANOSPHERES | West Virginia University (US) | 2022-10-19 | — | — | EP | claimed |
| US-11389311-B2 | Braided flow diverter using flat-round technology | DePuy Synthes Products, Inc. (US) | 2022-07-19 | — | — | US | claimed |
| US-20220218878-A1 | CONTROLLED HEAT DELIVERY COMPOSITIONS | BAMBU VAULT LLC (US) | 2022-07-14 | — | — | US | claimed |
| CN-114191436-A | Synthetic method of bionic macrophage membrane nano drug-loaded particles and application of bionic macrophage membrane nano drug-loaded particles in new coronavirus pneumonia | 中山大学附属第五医院 | 2022-03-18 | — | — | CN | claimed |
| EP-2398503-A2 | GADOLINIUM EXPRESSED LIPID NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING | University Of Washington (US) | 2011-12-28 | — | — | EP | claimed |
| US-7923034-B2 | Process for producing microparticles | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2011-04-12 | — | — | US | claimed |
| WO-2010094043-A2 | GADOLINIUM EXPRESSED LIPID NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING | UNIVERSITY OF WASHINGTON (US) | 2010-08-19 | — | — | WO | claimed |
| US-20060134223-A1 | Process for producing microparticles | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2006-06-22 | — | — | US | claimed |
| EP-1629833-A1 | PROCESS FOR PRODUCING MICROPARTICLE | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2006-03-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083669-A1 | AQUEOUS GEL COMPOSITION | CFTR, AQP3, SLC26A4 | MMP1 2510/4885MMP2 1571/4885MMP3 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.